We’re looking forward to attending Digestive Disease Week (DDW) 2026, where we’ll highlight our expanding cancer diagnostic portfolio. New data from multiple abstracts across colorectal, liver, and esophageal cancers demonstrate exciting changes in cancer screening and our commitment to improving patient outcomes. Read more: http://spr.ly/6041BBT8SR #DDW2026
About us
Exact Sciences is now @Abbott. Together, we will transform the way the world approaches cancer. Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Content reflects information available and is accurate at the time of publication.
- Website
-
http://exactsciences.com
External link for Exact Sciences
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Madison, Wisconsin
- Type
- Public Company
- Specialties
- Precision oncology, Genomic testing, Cancer screening, Genetic testing, and Research and development
Locations
Employees at Exact Sciences
Updates
-
How do clinicians give patients clearer answers about their cancer? Molecular residual disease (MRD) testing could play a central part in furthering individualized patient care. Recent data presented at the American Association for Cancer Research (AACR) Annual Meeting highlight the potential role of MRD testing in triple-negative breast cancer. Read more via Rick Baehner, MD: http://spr.ly/6042B6haaE
-
-
New data at AACR 2026 demonstrate how the Cancerguard® test’s multi-biomarker class approach improves early-stage cancer detection. Read more: http://spr.ly/6040B6Ap1i
-
-
We’re expanding access to our Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers through an integration with Flatiron Health's OncoEMR® platform. This integration will help accelerate informed treatment decisions by enabling oncologists to order tests and view results directly in the clinical workflow. Read more: http://spr.ly/6043B6mVNF
-
-
We’re proud to support a new nationwide initiative with Walgreens and Workflow Services designed to help close the colorectal cancer screening gap and help detect colorectal cancer earlier, when it is most treatable. Through an enhanced Walgreens website experience, eligible patients can learn about their screening options and, if appropriate, request the Cologuard® test through the Workflow Services platform, creating a simple path from awareness to action. This effort is expected to reach more than 2 million eligible patients nationwide. 🔗 http://spr.ly/6041B6j77z
-
We're excited to join Abbott. Together, we share a simple, powerful purpose: helping people live fuller lives through better health. We look forward to transforming how the world approaches cancer and supporting even more people as we tackle one of the world's biggest health challenges. https://lnkd.in/gEPTeF_Z
-
-
Blue looks good on us 💙 The sense of community here is truly special. Thank you to everyone who made this year’s Cologuard Classic by Exact Sciences the best one yet!
-
-
-
-
-
+5
-
-
Things are off to a great start here in Tucson, AZ at the Cologuard Classic by Exact Sciences! After a night of honoring the more than 450 colorectal cancer patients, survivors, caregivers, and loved ones in attendance, we kicked things off on Friday morning with a special opening ceremony. Special thanks to Katie Couric and Simone Boseman for being here and for all you do to advocate and raise awareness for colorectal cancer. 💙
-
-
-
-
-
+3
-
-
Colorectal cancer has a way of taking control of timelines, plans, and choices. We spoke with experts and patients about how we can take back that control. Thank you to patient ambassadors Tim, Anne, and Scott, for sharing your stories: http://spr.ly/6044B6XNxe
-